Table 2.
VPZ group |
PPI group |
|||||||
Eradication rate | OR | 95%CI | P value | Eradication rate | OR | 95%CI | P value | |
Sex | ||||||||
Male | 90.2% | 1 | 67.0% | 1 | ||||
Female | 86.3% | 0.682 | 0.396-1.174 | 0.17 | 66.9% | 0.995 | 0.737-1.343 | 0.97 |
Age (yr) | ||||||||
< 60 | 86.6% | 1 | 74.1% | 1 | ||||
≥ 60 | 87.9% | 1 | 0.598-1.673 | 1 | 76.7% | 1.155 | 0.860-1.551 | 0.34 |
BMI (kg/m2) | ||||||||
< 25 | 88.4% | 1 | 69.1% | 1 | ||||
≥ 25 | 86.5% | 0.843 | 0.464-1.530 | 0.57 | 68.8% | 0.987 | 0.683-1.435 | 0.94 |
Smoking | ||||||||
No | 87.3% | 1 | 68.1% | 1 | ||||
Yes | 91.3% | 1.412 | 0.583-3.420 | 0.44 | 56.6% | 0.611 | 0.412-0.906 | 0.01 |
Alcohol | ||||||||
Non-drinker | 88.1% | 1 | 67.7% | 1 | ||||
Drinker | 87.4% | 0.937 | 0.555-1.580 | 0.81 | 67.3% | 0.984 | 0.716-1.352 | 0.92 |
Atrophy | ||||||||
Closed type | 87.9% | 1 | 65.6% | 1 | ||||
Open type | 89.1% | 1.130 | 0.619-2.069 | 0.69 | 65.6% | 0.998 | 0.708-1.408 | 0.99 |
VPZ: Vonoprazan; PPI: Proton pump inhibitor.